Thank you for joining us at the Oligonucleotide & Precision Therapeutics Conference & Exhibition.
OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. It brings together leading discovery and development scientists, CMC and regulatory experts, and technology providers, to help you optimize drug design and delivery, streamline manufacturing and regulatory issues and accelerate time to market.